InvaTech Pharma Solutions, LLC recalls Levocetirizine Dihydrochloride Tablets, USP, 5 mg 30-count bottle, Rx Only, Distributed by: Marlex Pharmceuticals, Inc.…
- Recall date
- November 11, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0115-2021
- FDA classification
- Class III
- Brand / firm
- InvaTech Pharma Solutions, LLC
- Sold / distributed
- Distributed Nationwide in the USA
Why it was recalled
Failed Impurities/Degradation Specifications: One lot of Levocetirizine dihydrochloride tablets 5 mg 30 count failed stability testing.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Levocetirizine Dihydrochloride Tablets, USP, 5 mg 30-count bottle, Rx Only, Distributed by: Marlex Pharmceuticals, Inc. New Castle, DE 19720. NDC 10135-0639-30
Get recall alerts
Free email alert whenever InvaTech Pharma Solutions, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: InvaTech Pharma Solutions, LLC